KN057

DRUG4 trials

Sponsors

Suzhou Alphamab Co., Ltd.

Conditions

Hemophilia A With InhibitorHemophilia A Without InhibitorHemophilia A or BHemophilia B With InhibitorHemophilia B Without InhibitorHemophilia a and B

Phase 2

KN057 Multiple Dose Study in Patients with Hemophilia a or Hemophilia B with or Without Inhibitors

Not yet recruitingNCT06747416

Suzhou Alphamab Co., Ltd.Hemophilia a and B

Start: 2025-09-02End: 2026-12-31Target: 24Updated: 2024-12-24

Phase 3

Efficacy and Safety of KN057 Prophylaxis in Patients With Haemophilia A or B With Inhibitors

Active, not recruitingNCT06312475

Suzhou Alphamab Co., Ltd.Hemophilia A With Inhibitor, Hemophilia B With Inhibitor

Start: 2024-01-09End: 2025-12-15Updated: 2025-09-17

Efficacy and Safety of KN057 Prophylaxis in Patients With Haemophilia A or B Without Inhibitors

Active, not recruitingNCT06569108

Suzhou Alphamab Co., Ltd.Hemophilia A Without Inhibitor, Hemophilia B Without Inhibitor

Start: 2024-04-01End: 2026-12-15Updated: 2025-09-17

Safety of KN057 Prophylaxis in Patients With Haemophilia A or B

RecruitingNCT07545395

Suzhou Alphamab Co., Ltd.Hemophilia A or B

Start: 2026-03-13End: 2028-03-30Target: 70Updated: 2026-04-22